erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
he said: "greater and immediate attention needs to be applied in these two areas.".
now the country may face a fine of millions of euros after its dereliction was referred to the european court of justice (ecj), the guardian reports..